Differences in caveolae dynamics in vascular smooth muscle cells of different phenotypes

Laboratory Investigation

Volumn 80, Issue 6, 2000, Pages 915-929

  Thyberg, Johan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; CHOLERA TOXIN B SUBUNIT; CHOLESTEROL; FILIPIN; LIPOPROTEIN;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYTOPLASM VESICLE; ENDOPLASMIC RETICULUM; INTERNALIZATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0033945385     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780095     Document Type: Article

References (51)

1. Andersen RGW (1998). The caveolae membrane system. Annu Rev Biochem 67:199-225.
2. Bist A, Fielding PE, and Fielding CJ (1997). Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proc Natl Acad Sci USA 94: 10693-10698.
3. Börnig H and Geyer G (1974). Staining of cholesterol with the fluorescent antibiotic filipin. Acta Histochem 50:110-115.
4. Brown MS and Goldstein JL (1986). A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47.
5. Campbell JH, Popadynec L, Nestel PJ, and Campbell GR (1983). Lipid accumulation in arterial smooth muscle cells. Influence of phenotype. Atherosclerosis 47:279-295.
6. Campbell JH, Reardon MF, Campbell GR, and Nestel PJ (1985). Metabolism of atherogenic lipoproteins by smooth muscle cells of different phenotype in culture. Arteriosclerosis 5:318-328.
7. Conrad PA, Smart EJ, Ying Y-S, Anderson RGW, and Bloom GS (1995). Caveolin cycles between plasma membrane caveolae and the Golgi complex by microtubule-dependent and microtubule-independent steps. J Cell Biol 131:1421-1433.
8. Critchley DR, Streuli CH, Kellie S, Ansell S, and Patel B (1982). Characterization of the cholera toxin receptor on Balb/c 3T3 cells as a ganglioside similar to, or identical with, ganglioside GM1. Biochem J 204:209-219.
9. Fielding PE and Fielding CJ (1995). Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry 34:14288-14292.
10. Fielding PE and Fielding CJ (1996). Intracellular transport of low density lipoprotein derived free cholesterol begins at clathrin-coated pits and terminates at cell surface caveolae. Biochemistry 35:14932-14938.
11. Fielding CJ and Fielding PE (1997). Intracellular cholesterol transport. J Lipid Res 38:1503-1521.
12. Fielding CJ, Bist A, and Fielding PE (1997). Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc Natl Acad Sci USA 94:3753-3758.
13. Gu F and Gruenberg J (1999). Biogenesis of transport intermediates in the endocytic pathway. FEBS Lett 452:61-66.
14. Hedin U, Bottger BA, Forsberg E, Johansson S, and Thyberg J (1988). Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol 107:307-319.
15. Hedin U and Thyberg J (1987). Plasma fibronectin promotes modulation of arterial smooth-muscle cells from contractile to synthetic phenotype. Differentiation 33:239-246.
16. Henley JR, Krueger EWA, Oswald BJ, and McNiven MA (1998). Dynamin-mediated internalization of caveolae. J Cell Biol 141:85-99.
17. Kruth HS and Vaughan M (1980). Quantification of low density lipoprotein binding and cholesterol accumulation by single human fibroblasts using fluorescence microscopy. J Lipid Res 21:123-130.
18. Lencer WI, Hirst TR, and Holmes RK (1999). Membrane traffic and the cellular uptake of cholera toxin. Biochim Biophys Acta 1450:177-190.
19. Liscum L and Munn NJ (1999). Intracellular cholesterol transport. Biochim Biophys Acta 1438:19-37.
20. Luetterforst R, Stang E, Zorzi N, Carozzi A, Way M, and Parton RG (1999). Molecular characterization of caveolin association with the Golgi complex: Identification of a cis-Golgi targeting domain in the caveolin molecule. J Cell Biol 145:1443-1459.
21. Marsh M and McMahon T (1999). The structural era of endocytosis. Science 285:215-220.
22. Mellman I (1996). Endocytosis and molecular sorting. Annu Rev Cell Dev Biol 12:575-625.
23. Montesano R, Roth J, Robert A, and Orci L (1982). Noncoated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins. Nature 296:651-653.
24. Mora R, Bonilha VL, Marmorstein A, Scherer PE, Brown D, Lisanti MP, and Rodriguez-Boulan E (1999). Caveolin-2 localizes to the Golgi complex but redistributes to plasma membrane, caveolae, and rafts when co-expressed with caveolin-1. J Biol Chem 274:25708-25717.
25. Moremen KW, Touster O, and Robbins PW (1991). Novel purification of the catalytic domain of Golgi α-mannosidase II: Characterization and comparison with the intact enzyme. J Biol Chem 266:16876-16885.
26. Murata M, Peränen J, Schreiner R, Wieland F, Kurzchalia TV, and Simons K (1995). VIP21 caveolin is a cholesterol-binding protein. Proc Natl Acad Sci USA 92:10339-10343.
27. Oh P, McIntosh DP, and Schnitzer JE (1998). Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J Cell Biol 141:101-114.
28. Orci L, Montesano R, Meda P, Malaisse-Lagae F, Brown D, Perrelet A, and Vassalli P (1981). Heterogeneous distribution of filipin-cholesterol complexes across the cisternae of the Golgi apparatus. Proc Natl Acad Sci USA 78:293-297.
29. Orlandi PA and Fishman PH (1998). Filipin-dependent inhibition of cholera toxin: Evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 141: 905-915.
30. Owens GK (1995). Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75:487-517.
31. Parolini I, Sargiacomo M, Galbiati F, Rizzo G, Grignani F, Engelman JA, Okamoto T, Ikezu T, Scherer PE, Mora R, Rodriguez-Bolan E, Peschle C, and Lisanti MP (1999). Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the Golgi complex. J Biol Chem 274:25718-25725.
32. Parton RG (1994). Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J Histochem Cytochem 42:155-166.
33. Sandvig K, Garred Ø, and van Deurs B (1996). Thapsigargininduced transport of cholera toxin to the endoplasmic reticulum. Proc Natl Acad Sci USA 93:12339-12343.
34. Sandvig K, Ryd M, Garred Ø, Schweda E, Holm PK, and van Deurs B (1994). Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP. J Cell Biol 126:53-64.
35. Scherer PE, Lewis RY, Volonté D, Engelman JA, Galbiati F, Couet J, Kohtz DS, van Donselaar E, Peters P, and Lisanti MP (1997). Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem 272:29337-29346.
36. Schnitzer JE, Liu J, and Oh P (1995). Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases. J Biol Chem 270:14399-14404.
37. Schnitzer JE, Oh P, and McIntosh DP (1996). Role of GTP hydrolysis in fission of caveolae directly from plasma membranes. Science 274:239-242.
38. Simionescu N, Lupu F, and Simionescu M (1983). Rings of membrane sterols surround the openings of vesicles and fenestrae in capillary endothelium. J Cell Biol 97:1592-1600.
39. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, and Lisanti MP (1999). Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 19:7289-7304.
40. Smart EJ, Ying Y-S, Conrad PA, and Anderson RGW (1994). Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. J Cell Biol 127:1185-1197.
41. Smart EJ, Ying Y-S, Donzell WC, and Andersen RGW (1996). A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J Biol Chem 271:29427-29435.
42. Somlyo AP and Somlyo AV (1994). Signal transduction and regulation in smooth muscle. Nature 372:231-236.
43. Song KS, Scherer PE, Tang ZL, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, and Lisanti MP (1996). Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and cofractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 271:15160-15165.
44. Thyberg J (1996). Differentiated properties and proliferation of arterial smooth muscle cells in culture, Int Rev Cytol 169:183-265.
45. Thyberg J (1998). Phenotypic modulation of smooth muscle cells during formation of neointimal thickenings following vascular injury. Histol Histopathol 13:871-891.
46. Thyberg J, Calara F, Dimayuga P, Nilsson J, and Regnström J (1998). Role of caveolae in cholesterol transport in arterial smooth muscle cells exposed to lipoproteins in vitro and in vivo. Lab Invest 78:825-837.
47. Thyberg J, Hedin U, and Bottger BA (1990). Attachment Substrates for smooth muscle cells. In: Piper HM, editor. Cell culture techniques in heart and vessel research. Berlin: Springer-Verlag, 315-333.
48. Thyberg J, Palmberg L, Nilsson J, Ksiazek T, and Sjölund M (1983). Phenotype modulation in primary cultures of arterial smooth muscle cells. On the role of platelet-derived growth factor. Differentiation 25:156-167.
49. Thyberg J, Roy J, Tran PK, Blomgren K, Dumitrescu A, and Hedin U (1997). Expression of caveolae on the surface of rat arterial smooth muscle cells is dependent on the phenotypic state of the cells. Lab Invest 77:93-101.
50. Tran D, Carpentier J-L, Sawano F, Gorden P, and Orci L (1987). Ligands internalized through coated or noncoated invaginations follow a common intracellular pathway. Proc Natl Acad Sci USA 84:7957-7961.
51. Uittenbogaard A, Ying Y, and Smart EJ (1998). Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol trafficking. J Biol Chem 273:6525-6532.